• View the Talks
• 22 min
  1. Reputation, image and influence of the pharmaceutical industry: rebuilding the trust

  • Ms. Jane Parker
• 54 min
  2. Pricing, reimbursement and market access issues in the United States and Europe

  • Mr. Lee Blansett
  • Mr. Walter Colasante
• 41 min
  3. Pricing in the pharmaceutical industry

  • Dr. E. Mick Kolassa
• 42 min
  4. Understanding the physician

  • Mr. Mike Owen
• 33 min
  5. The future of branding within the pharmaceutical industry

  • Mr. Giles D. Moss
• 26 min
  6. The evolution and role of continuous medical education (CME)

  • Ms. Barbara Macelloni
• Archived Lectures *These may not cover the latest advances in the field
• 32 min
  7. Getting the most from your life sciences advertising agency: how can doctors be influenced?

  • Mr. Barry Gowers

Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Agenda
3. Why is it hard to find a senior medical writer?
4. Ground where stakeholders share interests/goals
5. ROI and medical education
6. A defining vision for medical education
7. Background
8. One fundamental difference
9. US CME regulation: ACCME
10. CME - US and European definitions
11. Promotional education vs. CME in Europe
12. The European differentiation
13. CME in Europe: there's room for harmonization
14. Pan-EU CME regulation (EACCME)
15. EACCME: standard for commercial sponsor (1)
16. EACCME: standard for commercial sponsor (2)
17. EACCME approach: quality aspects of CME
18. EACCME regulation: accredited activities
19. E-CME in Europe - UEMS/EACCME
20. EACCME: accreditation procedures
21. EU future challenges
22. MedEd through the brand life cycle
23. MedEd through the brand life cycle: objectives
24. MedEd through the brand life cycle: tasks
25. CME specific added values
26. Communication tactics overview
27. Planning the integration
28. Medical marketing strategy
29. Planning the integration: communication quadrant
30. Objectives-oriented medical education
31. MedEd - development process
32. CME vs. promotional MedEd - strategic choice (1)
33. CME vs. promotional MedEd - strategic choice (2)
34. Whatever the activities - some key considerations
35. An opportunity not to be missed
36. The medical education life cycle
37. Levels of outcomes analysis
38. A mutual need for cooperation: MedEd quadrant
39. Marketing and MedEd working together
40. Leading the integration
41. Integrated core teams: science and marketing
42. Involving representatives of all core disciplines
43. Orchestration of specialised units
44. CME specific competences
45. Concluding remark

Topics Covered

• CME evolution and current status: a focus on Europe
• Medical education: role through the brand life cycle and added value of CME
• Planning the integration: how to develop effective medical education consistent with the communication strategy
• Marketing and medical education departments working together: how to make it a win-win cooperation

Links

Series:

• Pharmaceutical Marketing

Categories:

• Pharmaceutical Sciences

Talk Citation

Publication History

• Published on February 25, 2009

Financial Disclosures

• Ms. Barbara Macelloni has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.